Published on Sep 22, Global Strategy for Asthma Management and Prevention The GINA reports are available on . IMPLEMENTATION OF ASTHMA GUIDELINES IN HEALTH SYSTEMS The GINA Assembly includes members from 45 countries, listed on the supported in – by unrestricted educational grants from the following. Guidelines on Definition, Evaluation, and Treatment of Severe Asthma • NAEPP or GINA guidelines over the 3 months or evaluation [20, 22]).


Author: Amely Dooley
Country: Latvia
Language: English
Genre: Education
Published: 10 October 2014
Pages: 728
PDF File Size: 18.42 Mb
ePub File Size: 1.79 Mb
ISBN: 233-3-73409-364-9
Downloads: 32917
Price: Free
Uploader: Amely Dooley


This article is one of a small annual allocation selected for open access publication at the discretion of the editor.


This article has been cited by other articles in PMC. Abstract Over the past 20 years, the Global Initiative for Asthma GINA has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for gina guidelines 2013 national guidelines.

However, uptake of existing guidelines is poor.

A major revision of the GINA report was published inand updated inreflecting an evolving understanding of heterogeneous airways disease, a broader evidence base, increasing interest in targeted gina guidelines 2013, and evidence about effective implementation approaches.

During development of the report, the clinical utility gina guidelines 2013 recommendations and strategies for their practical implementation were considered in parallel with the scientific evidence.


This article provides a summary of key changes in gina guidelines 2013 GINA report, and their rationale. Short abstract This paper summarises key changes in the GINA global strategy report, a practical new resource for asthma care http: The impact of asthma is gina guidelines 2013 not only by patients, but also by families, healthcare systems and society.

Asthma is one of the most common chronic diseases affecting children and young adults, and there is increasing recognition of its impact upon working-age adults, the importance of adult-onset asthma, and the contribution of undiagnosed asthma to respiratory symptoms and activity limitation in the elderly.


The Global Initiative for Asthma GINA was established in in gina guidelines 2013 with the National Heart, Lung and Blood Institute and the World Health Organization, under the leadership of Drs Suzanne Hurd and Claude Lenfant, gina guidelines 2013 the goals of disseminating information about asthma management, and providing a mechanism to translate scientific evidence into improved asthma care.

Substantial advances have been made in scientific knowledge about the nature of asthma, a wide range of new medications, and understanding of important emotional, behavioural, social and administrative aspects of asthma care.

However, in spite of these efforts, and the availability of highly effective therapies, international surveys provide ongoing evidence of suboptimal asthma control [ 6 — 8 ] and poor adherence to existing guidelines [ 9 — 11 ]. New approaches are needed.

Since the last major revision of the GINA report in [ 12 ], there gina guidelines 2013 been a transition in understanding of asthma and chronic obstructive pulmonary disease COPD as heterogeneous and sometimes overlapping conditions, awareness of the contribution of common problems such as adherence, inhaler technique and health literacy to poorly controlled asthma, an expanding research evidence base that incorporates highly controlled efficacy studies, pragmatic studies and observational data in broad populations [ 13 ], increasing interest in individualised healthcare, and growing attention to effective strategies for changing health-related behaviour.

A summary of the new GINA strategy: a roadmap to asthma control

This context is reflected in key changes in evidence, recommendations and format in the major revision of the GINA strategy report that was published in Mayand further updated in April The aim of this article is to summarise the key changes in the GINA strategy report, with a description of the rationale gina guidelines 2013 each change and a sample of clinical tools from the full report.

More detail about clinical recommendations and supporting evidence, and the full range of clinical tools, are available in the latest update of the full GINA report published in Aprilwhich is available from the GINA website www. gina guidelines 2013

  • Short abstract

An over-arching aim was to substantially restructure the report in order to facilitate its implementation in clinical practice, while gina guidelines 2013 the existing strong evidence base. Recognising that key images and tables in the report would have the greatest impact, we gina guidelines 2013 by soliciting broad input on three areas: Members of the multinational GINA Assembly, primary care clinicians, respiratory specialists and other expert advisers were asked to provide feedback about existing GINA materials on these topics, with regard to their evidence, clarity and feasibility for implementation in clinical practice, and to identify other sections in need of substantial revision.

Over 50 responses were received.

Importantly, the clinical relevance of recommendations, and strategies for their implementation, were considered in parallel with the review of scientific evidence. The final draft of the report was extensively peer-reviewed, with strongly supportive feedback received from over 40 reviewers including seven external reviewers.

The report was published on World Asthma Day in Maywith an update of new evidence in April Evidence-based recommendations need to be presented in a way that is both gina guidelines 2013 and relevant to clinicians, and integrated into gina guidelines 2013 that are feasible for health professionals to use in their busy clinical practice.

The GINA report, therefore, now focuses not only on the gina guidelines 2013 strong evidence base about what treatment should be recommended, but also on clarity of language and on inclusion of clinical tools evidence-based where possible for how this can be done in clinical practice.

Recommendations are now presented in a user-friendly way, with clear language and extensive use of summary tables, clinical tools and flow-charts.

The electronic gina guidelines 2013 includes hyperlinked cross-references for figures, tables and citations.